Search | WHO COVID-19 Research Database

Adamantiades-Behçet's disease (Behçet's disease) and COVID-19.

Zouboulis, C C; van Laar, J A M; Schirmer, M; Emmi, G; Fortune, F; Gül, A; Kirino, Y; Lee, E-S; Sfikakis, P P; Shahram, F; Wallace, G R.

J Eur Acad Dermatol Venereol ; 35(9): e541-e543, 2021 09.

Article in English | MEDLINE | ID: covidwho-1295047

Subject(s)

Behcet Syndrome , COVID-19 , Behcet Syndrome/diagnosis , Humans , SARS-CoV-2

Adamantiades-Behcet's disease (Behcet's disease) and COVID-19

Zouboulis, C. C.; van Laar, J. A. M.; Schirmer, M.; Emmi, G.; Fortune, F.; Gul, A.; Kirino, Y.; Lee, E. S.; Sfikakis, P. P.; Shahram, F.; Wallace, G. R..

Journal of the European Academy of Dermatology & Venereology ; 29:29, 2021.

Article in English | MEDLINE | ID: covidwho-1208398

ABSTRACT

The immunopathogenesis of COVID-19 remains ill-defined. Through hyperstimulation of the immune system, SARS-CoV2 may cause a multi-facetted inflammatory disease and generate immune-mediated organ damage even leading to fatal consequences. However, it is still unclear, if a modified course of COVID-19 occurs in patients with autoimmune and/or autoinflammatory diseases.

Subject(s)

ABSTRACT

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL